18 results on '"Widenmaier, Scott B."'
Search Results
2. Sterol O-acyltransferase (SOAT/ACAT) activity is required to form cholesterol crystals in hepatocyte lipid droplets
- Author
-
Bairos, Jordan A., Njoku, Uche, Zafar, Maria, Akl, May G., Li, Lei, Parlakgul, Gunes, Arruda, Ana Paula, and Widenmaier, Scott B.
- Published
- 2024
- Full Text
- View/download PDF
3. Complementary gene regulation by NRF1 and NRF2 protects against hepatic cholesterol overload
- Author
-
Akl, May G., Li, Lei, Baccetto, Raquel, Phanse, Sadhna, Zhang, Qingzhou, Trites, Michael J., McDonald, Sherin, Aoki, Hiroyuki, Babu, Mohan, and Widenmaier, Scott B.
- Published
- 2023
- Full Text
- View/download PDF
4. Protective Effects of Hepatocyte Stress Defenders, Nrf1 and Nrf2, against MASLD Progression.
- Author
-
Akl, May G., Li, Lei, and Widenmaier, Scott B.
- Subjects
HEPATIC fibrosis ,GREEN fluorescent protein ,HIGH-fat diet ,LIVER cells ,HEPATITIS ,LIVER regeneration - Abstract
Progression of metabolic dysfunction-associated steatites liver disease (MASLD) to steatohepatitis (MASH) is driven by stress-inducing lipids that promote liver inflammation and fibrosis, and MASH can lead to cirrhosis and hepatocellular carcinoma. Previously, we showed coordinated defenses regulated by transcription factors, nuclear factor erythroid 2-related factor-1 (Nrf1) and -2 (Nrf2), protect against hepatic lipid stress. Here, we investigated protective effects of hepatocyte Nrf1 and Nrf2 against MASH-linked liver fibrosis and tumorigenesis. Male and female mice with flox alleles for genes encoding Nrf1 (Nfe2l1), Nrf2 (Nfe2l2), or both were fed a MASH-inducing diet enriched with high fat, fructose, and cholesterol (HFFC) or a control diet for 24–52 weeks. During this period, hepatocyte Nrf1, Nrf2, or combined deficiency for ~7 days, ~7 weeks, and ~35 weeks was induced by administering mice hepatocyte-targeting adeno-associated virus (AAV) expressing Cre recombinase. The effects on MASH, markers of liver fibrosis and proliferation, and liver tumorigenesis were compared to control mice receiving AAV-expressing green fluorescent protein. Also, to assess the impact of Nrf1 and Nrf2 induction on liver fibrosis, HFFC diet-fed C57bl/6J mice received weekly injections of carbon tetrachloride, and from week 16 to 24, mice were treated with the Nrf2-activating drug bardoxolone, hepatocyte overexpression of human NRF1 (hNRF1), or both, and these groups were compared to control. Compared to the control diet, 24-week feeding with the HFFC diet increased bodyweight as well as liver weight, steatosis, and inflammation. It also increased hepatocyte proliferation and a marker of liver damage, p62. Hepatocyte Nrf1 and combined deficiency increased liver steatosis in control diet-fed but not HFFC diet-fed mice, and increased liver inflammation under both diet conditions. Hepatocyte Nrf1 deficiency also increased hepatocyte proliferation, whereas combined deficiency did not, and this also occurred for p62 level in control diet-fed conditions. In 52-week HFFC diet-fed mice, 35 weeks of hepatocyte Nrf1 deficiency, but not combined deficiency, resulted in more liver tumors in male mice, but not in female mice. In contrast, hepatocyte Nrf2 deficiency had no effect on any of these parameters. However, in the 15-week CCL4-exposed and 24-week HFFC diet-fed mice, Nrf2 induction with bardoxolone reduced liver steatosis, inflammation, fibrosis, and proliferation. Induction of hepatic Nrf1 activity with hNRF1 enhanced the effect of bardoxolone on steatosis and may have stimulated liver progenitor cells. Physiologic Nrf1 delays MASLD progression, Nrf2 induction alleviates MASH, and combined enhancement synergistically protects against steatosis and may facilitate liver repair. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Brown adipose tissue thermogenic adaptation requires Nrf1-mediated proteasomal activity
- Author
-
Bartelt, Alexander, Widenmaier, Scott B, Schlein, Christian, Johann, Kornelia, Goncalves, Renata L S, Eguchi, Kosei, Fischer, Alexander W, Parlakgül, Günes, Snyder, Nicole A, Nguyen, Truc B, Bruns, Oliver T, Franke, Daniel, Bawendi, Moungi G, Lynes, Matthew D, Leiria, Luiz O, Tseng, Yu-Hua, Inouye, Karen E, Arruda, Ana Paula, and Hotamisligil, Gökhan S
- Subjects
Obesity -- Genetic aspects -- Development and progression -- Care and treatment ,Cell metabolism -- Genetic aspects -- Health aspects ,Adipose tissue -- Genetic aspects -- Health aspects ,Transcription factors -- Health aspects ,Biological sciences ,Health - Abstract
Adipocytes possess remarkable adaptive capacity to respond to nutrient excess, fasting or cold exposure, and they are thus an important cell type for the maintenance of proper metabolic health. Although the endoplasmic reticulum (ER) is a critical organelle for cellular homeostasis, the mechanisms that mediate adaptation of the ER to metabolic challenges in adipocytes are unclear. Here we show that brown adipose tissue (BAT) thermogenic function requires an adaptive increase in proteasomal activity to secure cellular protein quality control, and we identify the ER-localized transcription factor nuclear factor erythroid 2-like 1 (Nfe2l1, also known as Nrf1) as a critical driver of this process. We show that cold adaptation induces Nrf1 in BAT to increase proteasomal activity and that this is crucial for maintaining ER homeostasis and cellular integrity, specifically when the cells are in a state of high thermogenic activity. In mice, under thermogenic conditions, brown-adipocyte-specific deletion of Nfe2l1 (Nrf1) resulted in ER stress, tissue inflammation, markedly diminished mitochondrial function and whitening of the BAT. In mouse models of both genetic and dietary obesity, stimulation of proteasomal activity by exogenously expressing Nrf1 or by treatment with the proteasome activator PA28[alpha] in BAT resulted in improved insulin sensitivity. In conclusion, Nrf1 emerges as a novel guardian of brown adipocyte function, providing increased proteometabolic quality control for adapting to cold or to obesity., Author(s): Alexander Bartelt [1]; Scott B Widenmaier [1]; Christian Schlein [1]; Kornelia Johann [1]; Renata L S Goncalves [1]; Kosei Eguchi [1]; Alexander W Fischer [1]; Günes Parlakgül [1]; Nicole [...]
- Published
- 2018
- Full Text
- View/download PDF
6. HDL functionality is dependent on hepatocyte stress defense factors Nrf1 and Nrf2.
- Author
-
Trites, Michael J., Stebbings, Brynne M., Hiroyuki Aoki, Phanse, Sadhna, Akl, May G., Lei Li, Babu, Mohan, and Widenmaier, Scott B.
- Subjects
HIGH density lipoproteins ,NUCLEAR factor E2 related factor ,HIGH cholesterol diet ,HDL cholesterol ,TUMOR necrosis factors ,TRANSCRIPTION factors ,APOLIPOPROTEIN E4 - Abstract
High density lipoproteins (HDL) promote homeostasis and counteract stressful tissue damage that underlie cardiovascular and other diseases by mediating reverse cholesterol transport, reducing inflammation, and abrogating oxidative damage. However, metabolically stressful conditions associated with atherosclerosis can impair these effects. Hepatocytes play a major role in the genesis and maturation of circulating HDL, and liver stress elicits marked regulatory changes to circulating HDL abundance and composition, which affect its functionality. The mechanisms linking liver stress to HDL function are incompletely understood. In this study, we sought to determine whether stress defending transcription factors nuclear factor erythroid 2 related factor-1 (Nrf1) and −2 (Nrf2) promote hepatocyte production of functional HDL. Using genetically engineered mice briefly fed a mild metabolically stressful diet, we investigated the effect of hepatocyte-specific deletion of Nrf1, Nrf2, or both on circulating HDL cholesterol, protein composition, and function. Combined deletion, but not single gene deletion, reduced HDL cholesterol and apolipoprotein A1 levels as well as the capacity of HDL to accept cholesterol undergoing efflux from cultured macrophages and to counteract tumor necrosis factor α-induced inflammatory effect on cultured endothelial cells. This coincided with substantial alteration to the HDL proteome, which correlated with liver gene expression profiles of corresponding proteins. Thus, our findings show complementary actions by hepatocyte Nrf1 and Nrf2 play a role in shaping HDL abundance and composition to promote production of functionally viable HDL. Consequently, our study illuminates the possibility that enhancing stress defense programming in the liver may improve atheroprotective and perhaps other health promoting actions of HDL. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. Coordinated regulation of protein synthesis and degradation by mTORC1
- Author
-
Zhang, Yinan, Nicholatos, Justin, Dreier, John R., Ricoult, Stephane J.H., Widenmaier, Scott B., Hotamisligil, Gokhan S., Kwiatkowski, David J., and Manning, Brendan D.
- Subjects
Proteolysis -- Genetic aspects ,Protein biosynthesis -- Genetic aspects ,Genetic regulation -- Physiological aspects ,Cellular signal transduction -- Genetic aspects ,Environmental issues ,Science and technology ,Zoology and wildlife conservation - Abstract
Eukaryotic cells coordinately control anabolic and catabolic processes to maintain cell and tissue homeostasis. Mechanistic target of rapamycin complex 1 (mTORC1) promotes nutrient-consuming-anabolic processes, such as protein synthesis (1). Here we show that as well as increasing protein synthesis, mTORC1 activation in mouse and human cells also promotes an increased capacity for protein degradation. Cells with activated mTORC1 exhibited elevated levels of intact and active proteasomes through a global increase in the expression of genes encoding proteasome subunits. The increase in proteasome gene expression, cellular proteasome content, and rates of protein turnover downstream of mTORC1 were all dependent on induction of the transcription factor nuclear factor erythroid-derived 2-related factor 1 (NRF1; also known as NFE2L1). Genetic activation of mTORC1 through loss of the tuberous sclerosis complex tumour suppressors, TSC1 or TSC2, or physiological activation of mTORC1 in response to growth factors or feeding resulted in increased NRF1 expression in cells and tissues. We find that this NRF1-dependent elevation in proteasome levels serves to increase the intracellular pool of amino acids, which thereby influences rates of new protein synthesis. Therefore, mTORC1 signalling increases the efficiency of proteasome-mediated protein degradation for both quality control and as a mechanism to supply substrate for sustained protein synthesis., In response to growth signals, mTORC1 promotes anabolic processes, such as protein synthesis, and its chronic activation is believed to underlie a variety of complex human diseases, including cancer and [...]
- Published
- 2014
8. Bcl-2 and Bcl-xL Suppress Glucose Signaling in Pancreatic β-Cells
- Author
-
Luciani, Dan S., White, Sarah A., Widenmaier, Scott B., Saran, Varun V., Taghizadeh, Farnaz, Hu, Xiaoke, Allard, Michael F., and Johnson, James D.
- Published
- 2013
- Full Text
- View/download PDF
9. Only iron-limited cells of the cyanobacterium Anabaena flos-aquae inhibit growth of the green alga Chlamydomonas reinhardtii
- Author
-
Matz, Carlyn J, Christensen, Michael R, Bone, Auralee D, Gress, Courtney D, Widenmaier, Scott B, and Weger, Harold G
- Published
- 2004
10. Proteostasis in thermogenesis and obesity.
- Author
-
Bartelt, Alexander and Widenmaier, Scott B.
- Subjects
- *
WHITE adipose tissue , *BROWN adipose tissue , *UNFOLDED protein response , *BODY temperature regulation , *ADIPOSE tissues , *METABOLIC disorders - Abstract
The proper production, degradation, folding and activity of proteins, proteostasis, is essential for any cellular function. From single cell organisms to humans, selective pressures have led to the evolution of adaptive programs that ensure proteins are properly produced and disposed of when necessary. Environmental factors such as temperature, nutrient availability, pathogens as well as predators have greatly influenced the development of mechanisms such as the unfolded protein response, endoplasmic reticulum-associated protein degradation and autophagy, working together in concert to secure cellular proteostasis. In our modern society, the metabolic systems of the human body face the distinct challenge of changed diets, chronic overnutrition and sedentary lifestyles. Obesity and excess white adipose tissue accumulation are linked to a cluster of metabolic diseases and disturbed proteostasis is a common feature. Conversely, processes that promote energy expenditure such as exercise, shivering as well as non-shivering thermogenesis by brown adipose tissue (BAT) and beige adipocytes counteract metabolic dysfunction. Here we review the basic concepts of proteostasis in obesity-linked metabolic diseases and focus on adipocytes, which are critical regulators of mammalian energy metabolism. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
11. Immune Cell Intolerance for Excess Cholesterol.
- Author
-
Widenmaier, Scott B. and Hotamışlıgil, Gökhan S.
- Subjects
- *
CHOLESTEROL , *METABOLIC disorders , *PHYSIOLOGY , *IMMUNOGLOBULINS , *AUTOIMMUNE diseases - Abstract
Chronic metabolic challenges have severe consequences on physiological systems. In this issue of Immunity , Ito et al. (2016) show that defects in cholesterol metabolism in CD11c + immune cells result in impaired antigen presentation and ultimately in autoimmune disease. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
12. Bcl-2 and Bcl-xL Suppress Glucose Signaling in Pancreatic β-Cells.
- Author
-
Luciani, Dan S., White, Sarah A., Widenmaier, Scott B., Saran, Varun V., Taghizadeh, Farnaz, Hu, Xiaoke, Allard, Michael F., and Johnson, James D.
- Subjects
PANCREATIC beta cells ,B cells ,LYMPHOMAS ,BLOOD sugar ,OBESITY - Abstract
B-cell lymphoma 2 (Bcl-2) family proteins are established regulators of cell survival, but their involvement in the normal function of primary cells has only recently begun to receive attention. In this study, we demonstrate that chemical and genetic loss-of-function of antiapoptotic Bcl-2 and Bcl-x
L significantly augments glucose-dependent metabolic and Ca2+ signals in primary pancreatic β-cells. Antagonism of Bcl-2/Bcl-xL by two distinct small-molecule compounds rapidly hyperpolarized b-cell mitochondria, increased cytosolic Ca2+ , and stimulated insulin release via the ATP-dependent pathway in β-cell under substimulatory glucose conditions. Experiments with single and double Bax--Bak knockout β-cells established that this occurred independently of these proapoptotic binding partners. Pancreatic β-cells from Bcl-2-/- mice responded to glucose with significantly increased NAD(P)H levels and cytosolic Ca2+ signals, as well as significantly augmented insulin secretion. Inducible deletion of Bcl-xL in adult mouse β-cells also increased glucose-estimulated NAD(P)H and Ca2+ responses and resulted in an improvement of in vivo glucose tolerance in the conditional Bcl-xL knockout animals. Our work suggests that prosurvival Bcl proteins normally dampen the β-cell response to glucose and thus reveals these core apoptosis proteins as integrators of cell death and physiology in pancreatic β-cells. [ABSTRACT FROM AUTHOR]- Published
- 2013
- Full Text
- View/download PDF
13. A GIP Receptor Agonist Exhibits β-Cell Anti-Apoptotic Actions in Rat Models of Diabetes Resulting in Improved β-Cell Function and Glycemic Control.
- Author
-
Widenmaier, Scott B., Su-Jin Kim, Yang, Gary K., Reyes, Thomas De Los, Nian, Cuilan, Asadi, Ali, Seino, Yutaka, Kieffer, Timothy J., Yin Nam Kwok, and McIntosh, Christopher H. S.
- Subjects
- *
GASTROINTESTINAL hormones , *FAT cells , *THERAPEUTICS , *GLUCOSE , *PEOPLE with diabetes , *LABORATORY rats , *PANCREAS , *STREPTOZOTOCIN , *LIPOPROTEINS , *INSULIN - Abstract
Aims: The gastrointestinal hormone GIP promotes pancreatic islet function and exerts pro-survival actions on cultured β-cells. However, GIP also promotes lipogenesis, thus potentially restricting its therapeutic use. The current studies evaluated the effects of a truncated GIP analog, D-Ala²-GIP1-30 (D-GIP1-30), on glucose homeostasis and β-cell mass in rat models of diabetes. Materials and Methods: The insulinotropic and pro-survival potency of D-GIP1-30 was evaluated in perfused pancreas preparations and cultured INS-1 β-cells, respectively, and receptor selectivity evaluated using wild type and GIP receptor knockout mice. Effects of D-GIP1-30 on β-cell function and glucose homeostasis, in vivo, were determined using Lean Zucker rats, obese Vancouver diabetic fatty rats, streptozotocin treated rats, and obese Zucker diabetic fatty rats, with effects on β-cell mass determined in histological studies of pancreatic tissue. Lipogenic effects of D-GIP1-30 were evaluated on cultured 3T3-L1 adipocytes. Results: Acutely, D-GIP1-30 improved glucose tolerance and insulin secretion. Chronic treatment with D-GIP1-30 reduced levels of islet pro-apoptotic proteins in Vancouver diabetic fatty rats and preserved β-cell mass in streptozotocin treated rats and Zucker diabetic fatty rats, resulting in improved insulin responses and glycemic control in each animal model, with no change in body weight. In in vitro studies, D-GIP1-30 exhibited equivalent potency to GIP1-42 on β-cell function and survival, but greatly reduced action on lipoprotein lipase activity in 3T3-L1 adipocytes. Conclusions: These findings demonstrate that truncated forms of GIP exhibit potent anti-diabetic actions, without pro-obesity effects, and that the C-terminus contributes to the lipogenic actions of GIP. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
14. Suppression of p38 MAPK and JNK via Akt-mediated Inhibition of Apoptosis Signal-regulating Kinase 1 Constitutes a Core Component of the β-Cell Pro-survival Effects of Glucose-dependent Insulinotropic PoIypeptide.
- Author
-
Widenmaier, Scott B., Ziliang Ao, Su-Jin Kim, Warnock, Garth, and Mclntosh, Christopher H. S.
- Subjects
- *
POLYPEPTIDES , *INSULIN , *CELL proliferation , *GENETIC transcription , *APOPTOSIS , *ENZYME inhibitors , *ETOPOSIDE - Abstract
Glucose-dependent insulinotropic polypeptide (GIP) potentiates glucose-stimulated insulin secretion, insulin biosynthesis, and j3-cell proliferation and survival. In previous studies GIP was shown to promote a-cell survival by modulating the activity of multiple signaling modules and regulating gene transcription of pro-and anti-apoptotic bcl-2 family proteins. We have now evaluated the mechanisms by which GIP regulates the dynamic interactions between cytoplasmic bcl-2 family members and the mitochondria in INS-1 cells during apoptosis induced by treatment with staurosporine (STS), an activator of the mitochondria-mediated apoptotic pathway. STS induced translocation of bad and bimEL, activation of mitochondrial bax, release of mitochondrial cytochrome c, cleavage of caspase-3, and apoptosis. Each response was significantly diminished by GIP. Using selective enzyme inhibitors, overexpression of dominant-negative Akt, and Akt siRNA, it was demonstrated that GIP promoted j3-cell survival via Akt-dependent suppression of p38 MAPK and JNK and that combined inhibition was sufficient to explain the entire pro-survival responses to GIP during STS treatment. This signaling pathway also explained the pro-survival effects of GIP on INS-1 cells exposed to two other promoters of stress: thapsigargin (endoplasmic reticulum stress) and etoposide (genotoxic stress). Importantly, we discovered that GIP suppressed p38 MAPK and JNK via Akt-mediated changes in the phosphorylation state of the apoptosis signal-regulating kinase 1 in INS-1 cells and human islets, resulting in inhibition of its activity. Inhibition of apoptosis by GIP is therefore mediated via a key pathway involving Akt-dependent inhibition of apoptosis signal-regulating kinase 1, which subsequently prevents the pro-apoptotic actions of p38 MAPK and JNK. Glucose-dependent insulinotropic polypeptide (GIP) potentiates glucose-stimulated insulin secretion, insulin bio- synthesis, and β-cell proliferation and survival. In previous studies GIP was shown to promote β-cell survival by modulating the activity of multiple signaling modules and regulating gene transcription of pro-and anti-apoptotic bcl-2 family proteins. We have now evaluated the mechanisms by which GIP regulates the dynamic interactions between cytoplasmic bcl-2 family members and the mitochondria in INS-1 cells during apoptosis induced by treatment with staurosporine (STS), an activator of the mitochondria-mediated apoptotic pathway. STS induced translocation of bad and bimEL, activation of mitochondrial bax, release of mitochondrial cytochrome c, cleavage of caspase-3, and apoptosis. Each response was significantly diminished by GIP. Using selective enzyme inhibitors, overexpression of dominant-negative Akt, and Akt siRNA, it was demonstrated that GIP promoted β-cell survival via Akt-dependent suppression of p38 MAPK and JNK and that combined inhibition was sufficient to explain the entire pro-survival responses to GIP during STS treatment. This signaling pathway also explained the pro-survival effects of GIP on INS-1 cells exposed to two other promoters of stress: thapsigargin (endoplasmic reticulum stress) and etoposide (genotoxic stress). Importantly, we discovered that GIP suppressed p38 MAPK and JNK via Akt-mediated changes in the phosphorylation state of the apoptosis signal-regulating kinase 1 in INS-1 cells and human islets, resulting in inhibition of its activity. Inhibition of apoptosis by GIP is therefore mediated via a key pathway involving Akt-dependent inhibition of apoptosis signal-regulating kinase 1, which subsequently prevents the pro-apoptotic actions of p38 MAPK and JNK. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
15. Noncanonical Activation of Akt/Protein Kinase B in β-Cells by the Incretin Hormone Glucose-dependent Insulinotropic Polypeptide.
- Author
-
Widenmaier, Scott B., Sampaio, Arthur V., Underhill, Michael, and McIntosh, Christopher H. S.
- Subjects
- *
PROTEIN kinases , *SERINE , *PEPTIDE hormones , *GLUCAGON-like peptide 1 , *PHOSPHORYLATION , *TYPE 2 diabetes treatment , *THERAPEUTICS - Abstract
Therapeutics based on the actions of the incretin hormones, glucagon-like peptide-1 (GLP- 1) and glucose-dependent insuli-notropic polypeptide (GIP), have recently been introduced for the treatment of type 2 diabetes mellitus. The serine/threonine kinase Akt is a major mediator of incretin action on the pancreatic islet, increasing β-cell mass and function and promoting β-cell survival. The mechanisms underlying incretin activation of Akt are thought to involve an essential phosphoinositide 3-kinase-mediated phosphorylation of threonine 308, similar to the prototypical Akt activator, insulin-like growth factor-1 (IGF-1). In this study, using activity assays on immunoprecipitated Akt, we discovered that GIP and GLP-1 were capable of stimulating Akt in the INS-1 β-cell line and isolated mouse islets via a mechanism that did not require phosphoinositide 3-kinase or phosphorylation of Thr308 and Ser473, and this pathway involved the production of cAMP. Furthermore, we found that GIP stimulated anti-apoptotic signaling via this alternate mode of Akt activation. We conclude that incretins can activate Akt via a novel noncanonical mechanism that may provide an alternative therapeutic target for the treatment of type 2 diabetes mellitus and have broader implications for Akt physiology in human health and disease. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
16. Euglycemia is affected by stress defense factor hepatocyte NRF1, but not NRF2.
- Author
-
Akl, May G., Baccetto, Raquel, Stebbings, Brynne M., Li, Lei, and Widenmaier, Scott B.
- Subjects
- *
HYPERGLYCEMIA , *NUCLEAR factor E2 related factor , *COMPLEMENTATION (Genetics) , *TRANSCRIPTION factors , *GENETIC regulation , *SOMATOTROPIN - Abstract
Hepatocyte stress signaling has been established to alter glucose metabolism and impair systemic glucose homeostasis. In contrast, the role of stress defenses in the control of glucose homeostasis is less understood. Nuclear factor erythroid 2 related factor-1 (NRF1) and −2 (NRF2) are transcription factors that promote stress defense and can exert hepatocyte stress defense programming via complementary gene regulation. To identify whether there are independent or complementary roles of these factors in hepatocytes on glucose homeostasis, we investigated the effect of adult-onset, hepatocyte-specific deletion of NRF1, NRF2, or both on glycemia in mice fed 1–3 weeks with a mildly stressful diet enriched with fat, fructose, and cholesterol. Compared to respective control, NRF1 deficiency and combined deficiency reduced glycemia, in some cases resulting in hypoglycemia, whereas there was no effect of NRF2 deficiency. However, reduced glycemia in NRF1 deficiency did not occur in the leptin-deficient mouse model of obesity and diabetes, suggesting hepatocyte NRF1 support defenses that counteract hypoglycemia but does not promote hyperglycemia. Consistent with this, NRF1 deficiency was associated with reduced liver glycogen and glycogen synthase expression as well as marked alteration to circulating level of glycemia-influencing hormones, growth hormone and insulin-like growth factor-1 (IGF1). Overall, we identify a role for hepatocyte NRF1 in modulating glucose homeostasis, which may be linked to liver glycogen storage and the growth hormone/IGF1 axis. • Hepatocyte NRF1 deficiency lowers glycemia, but does not promote hyperglycemia. • In contrast, hepatocyte NRF2 deficiency has no effect on glycemia. • Hepatocyte NRF1 promotes glycogen synthase expression and glycogen storage. • Hepatocyte NRF1 promotes the growth hormone/insulin-like growth factor 1 axis. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
17. Immunometabolic factors contributing to obesity-linked hepatocellular carcinoma.
- Author
-
Akl MG and Widenmaier SB
- Abstract
Hepatocellular carcinoma (HCC) is a major public health concern that is promoted by obesity and associated liver complications. Onset and progression of HCC in obesity is a multifactorial process involving complex interactions between the metabolic and immune system, in which chronic liver damage resulting from metabolic and inflammatory insults trigger carcinogenesis-promoting gene mutations and tumor metabolism. Moreover, cell growth and proliferation of the cancerous cell, after initiation, requires interactions between various immunological and metabolic pathways that provide stress defense of the cancer cell as well as strategic cell death escape mechanisms. The heterogenic nature of HCC in addition to the various metabolic risk factors underlying HCC development have led researchers to focus on examining metabolic pathways that may contribute to HCC development. In obesity-linked HCC, oncogene-induced modifications and metabolic pathways have been identified to support anabolic demands of the growing HCC cells and combat the concomitant cell stress, coinciding with altered utilization of signaling pathways and metabolic fuels involved in glucose metabolism, macromolecule synthesis, stress defense, and redox homeostasis. In this review, we discuss metabolic insults that can underlie the transition from steatosis to steatohepatitis and from steatohepatitis to HCC as well as aberrantly regulated immunometabolic pathways that enable cancer cells to survive and proliferate in the tumor microenvironment. We also discuss therapeutic modalities targeted at HCC prevention and regression. A full understanding of HCC-associated immunometabolic changes in obesity may contribute to clinical treatments that effectively target cancer metabolism., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Akl and Widenmaier.)
- Published
- 2023
- Full Text
- View/download PDF
18. NRF1 Is an ER Membrane Sensor that Is Central to Cholesterol Homeostasis.
- Author
-
Widenmaier SB, Snyder NA, Nguyen TB, Arduini A, Lee GY, Arruda AP, Saksi J, Bartelt A, and Hotamisligil GS
- Subjects
- Animals, CD36 Antigens metabolism, Fatty Liver metabolism, Gene Expression Regulation, Homeostasis, Humans, Liver cytology, Mice, Transcription, Genetic, Cholesterol metabolism, Endoplasmic Reticulum metabolism, Liver metabolism, Nuclear Respiratory Factor 1 metabolism
- Abstract
Cholesterol is a critical nutrient requiring tight constraint in the endoplasmic reticulum (ER) due to its uniquely challenging biophysical properties. While the mechanisms by which the ER defends against cholesterol insufficiency are well described, it remains unclear how the ER senses and effectively defends against cholesterol excess. Here, we identify the ER-bound transcription factor nuclear factor erythroid 2 related factor-1, Nrf1/Nfe2L1, as a critical mediator of this process. We show that Nrf1 directly binds to and specifically senses cholesterol in the ER through a defined domain and that cholesterol regulates Nrf1 turnover, processing, localization, and activity. In Nrf1 deficiency, in vivo cholesterol challenges induce massive hepatic cholesterol accumulation and damage, which is rescued by replacing Nrf1 exogenously. This Nrf1-mediated mechanism involves the suppression of CD36-driven inflammatory signaling and derepression of liver X receptor activity. These findings reveal Nrf1 as a guardian of cholesterol homeostasis and a core component of adaptive responses to excess cellular cholesterol., (Copyright © 2017. Published by Elsevier Inc.)
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.